Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy

Journal of Pharmaceutical Sciences

Volumn 102, Issue 6, 2013, Pages 1724-1733

  Amezcua, Carlos A ^a   Szabo, Christina M ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Biopharmaceuticals characterization; Diffusion; ECHOS NMR; Higher order structure comparability; NMR; NMR fingerprinting; Protein structure; Proteins; Spectroscopy

Indexed keywords

APROTININ;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIFFUSION; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

EID: 84877924380     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23531     Document Type: Article

References (20)

1. Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Food and Drug Administration. 2005. Q5E comparability of biotechnological/biological products subject to changes in their manufacturing process.
2. European Medicines Agency. 2005. ICH Topic Q5E, Comparability of Biotechnological/Biological Products.
3. Committee for Medicinal Products for Human Use. European Medicines Agency. 2006. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues.
4. Chirino AJ, Mire-Sluis A. 2004. Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 22(11):1383-1391.
5. Kranz J, Al-Azzam F, Saluja A, Svitel J, Al-Azzam W. 2013. Techniques for higher order structure determination. In Biophysics for therapeutic protein development, biophysics for the life sciences; Narhi L, Ed. New York: Springer, pp 33-82.
6. Wuthrich K. 2003. NMR studies of structure and function of biological macromolecules (Nobel Lecture). J Biomol NMR 27(1):13-39.
7. Freedberg DI. 2005. Using nuclear magnetic resonance spectroscopy to characterize biologicals. Dev Biol 122:77-83.
8. Zuperl S, Pristovsek P, Menart V, Gaberc-Porekar V, Novic M. 2007. Chemometric approach in quantification of structural identity/similarity of proteins in biopharmaceuticals. J Chem Inf Model 47(3):737-743.
9. Parsons IC, Lansing J, Bosques CJ, Beccati D. 2010. Comparative analysis of protein conformations by using 2D NOESY NMR spectra. United States Patent Publication US 2010/0188084 A1. pp 1-11.
10. Panjwani N, Hodgson DJ, Sauve S, Aubin Y. 2010. Assessment of the effects of pH, formulation and deformulation on the conformation of interferon alpha-2 by NMR. J Pharm Sci 99(8):3334-3342.
11. Aubin Y, Gingras G, Sauve S. 2008. Assessment of the three-dimensional structure of recombinant protein therapeutics by NMR fingerprinting: Demonstration on recombinant human granulocyte macrophage-colony stimulation factor. Anal Chem 80(7):2623-2627.
12. Zhou DH, Shah G, Mullen C, Sandoz D, Rienstra CM. 2009. Proton-detected solid-state NMR spectroscopy of natural-abundance peptide and protein pharmaceuticals. Angew Chem 48(7):1253-1256.
13. Sorgel F, Lerch H, Lauber T. 2010. Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product. BioDrugs 24(6):347-357.
14. Prestrelski SJ, Arakawa T, Carpenter JF. 1993. Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy. Arch Biochem Biophys 303(2):465-473.
15. Prestrelski SJ, Tedeschi N, Arakawa T, Carpenter JF. 1993. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J 65(2):661-671.
16. Dehner A, Kessler H. 2005. Diffusion NMR spectroscopy: Folding and aggregation of domains in p53. Chembiochem 6(9):1550-1565.
17. Li CH, Nguyen X, Narhi L, Chemmalil L, Towers E, Muzammil S, Gabrielson J, Jiang Y. 2011. Applications of circular dichroism (CD) for structural analysis of proteins: Qualification of near- and far-UV CD for protein higher order structural analysis. J Pharm Sci 100(11):4642-4654.
18. Jiang Y, Li C, Nguyen X, Muzammil S, Towers E, Gabrielson J, Narhi L. 2011. Qualification of FTIR spectroscopic method for protein secondary structural analysis. J Pharm Sci 100(11):4631-4641.
19. Jiang Y, Li C, Gabrielson J. 2013. Qualification of biophysical methods for the analysis of protein therapeutics. In Biophysics for therapeutic protein development, Biophysics for the life sciences; Narhi LO, Ed. New York: Springer, pp 99-126.
20. D'Antonio J, Murphy BM, Manning MC, Al-Azzam WA. 2012. Comparability of protein therapeutics: Quantitative comparison of second-derivative amide I infrared spectra. J Pharm Sci 101(6):2025-2033.